Lupride Depot 11.25mg (Leuprolide Acetate)

Introduction

Lupride Depot is a injection-able, long-acting formulation with Leuprolide Acetate in the dose of 11.25mg. Leuprolide Acetate is a synthetic gonadotropin-releasing hormone (GnRH) agonist widely used in various hormone-responsive conditions such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty.

The depot formulation permits the gradual and steady release of the drug for months, which reduces the necessity for repeated injections as well as increasing the level of compliance for patients.

What is Leuprolide Acetate?

• Generic Name: Leuprolide Acetate
• Brand Name: Lupride Depot (among others)
• Drug Class: GnRH agonist
• Formulation: Injectable depot suspension for intramuscular or subcutaneous injection
• Dose: 11.25 mg, typically administered every 3 months (quarterly)

Mechanism of Action

Leuprolide is one of the GnRH analogs, which initially triggers the pituitary glands to release thehormones luteinizing hormone (LH) and follicle-stimulating hormone (FSH). The result is a brief surge in hormones that are sex-specific (testosterone for males and estrogen for females).

In contrast, after continuous administration, Lupride Depot causes a reduction in GnRH receptors in the pituitary resultant in a drastic diminution in LH as well as FSH production. It results in a dramatic decrease in the production of sex hormones:

• For men, testosterone levels decrease to levels that are castration.
• For women, estrogen levels are lowered.

The substance “medical castration” or suppression of hormones is effective in the treatment of hormone-dependent disorders.

Indications and Uses

Lupride Depot 11.25mg is used to treat conditions that reduce testosterone levels is helpful:

In Males:

• Prostate cancer: It is used to reduce testosterone levels, which is the main ingredient in prostate tumors.
• Precocious puberty: To stop early puberty.

In Females:

• Endometriosis: Reduce estrogen levels and manage pain.
• Uterine fibroids: Reduce fibroids and lessen bleeding before surgery.
• Central precocious puberty: The purpose of this is to prevent the puberty process from beginning.

Dosage and Administration

• 11.25 mg depot injection 11.25 mg dose depot injection typically given at least once every three months (every 12 weeks) by deep intramuscular injection.
• In most cases, the injection is administered by a medical specialist.
• The dosage may differ based on the medical condition being treated and the response of the patient.
• Before starting the treatment, baseline hormone levels as well as clinical tests are suggested.

Pharmacokinetics

• The depot formulation offers an infrequent release of leuprolide over a period of weeks.
• Following injection, the levels of the drug gradually increase, creating an initial spike in hormone levels, which is then followed by a slowing down.
• The half-life of the form for depots is three months.
• The majority of peptidases are involved in metabolism; there is no evidence of hepatic metabolism.

Side Effects

Leuprolide Acetate can trigger side effects, which are mostly due to the hormone surge that caused it, as well as the subsequent suppression of hormones.

Common Side Effects:

• Hot flashes and sweating
• Headache
• Injection site reactions: pain, redness, swelling
• Mood changes or depression
• Decreased libido and erectile dysfunction (in men)
• Vaginal dryness or amenorrhea (in women)
• The pain of the bones or an increase in symptoms in patients with prostate cancer because of the initial surge in hormones
• Fatigue

Long-term risks:

• Density of bones decreases, which leads to osteoporosis
• Metabolic changes: weight gain, insulin resistance
• Cardiovascular risk (potentially increased)

Precautions and Contraindications

• Contraindicated in:
  • Hypersensitivity is a known complication of leuprolide and GnRH analogs
  • Pregnancy and breastfeeding (due to hormone suppression effects)
• Use with caution:
  • People with osteoporosis who are at risk for fractures
  • Patients with a heart condition
  • Check for signs of a tumor flare, particularly those with prostate cancer at the beginning of treatment
  • Health conditions related to mental health must be analyzed because mood swings can happen.

Monitoring During Therapy

• The baseline and the periodic measurements of levels of hormones that affect sex (testosterone or estrogen)
• Assessment of bone mineral density if the patient is undergoing long-term treatment
• Be aware of signs of disease development or symptom flare
• A regular assessment of risk factors for cardiovascular disease.
• Evaluation of the psychological state if mood fluctuations take place

Patient Counseling Points

• Inform patients of the likelihood of the initial surge in hormones causing symptoms flare (especially for prostate cancer). Sometimes, anti-androgens may be prescribed in the first few weeks.
• Provide advice on possible adverse consequences such as hot flashes, changes in mood, and sexual dysfunction.
• It is important to encourage Vitamin D and calcium supplementation, as well as lifestyle changes, to safeguard the health of your bones.
• Make sure you adhere to the injection schedule and appointments for follow-up.
• Women who are pregnant might stop in the course of treatment, and it is normal.

Storage

• The suspension that you inject can be stored in the refrigerator between 2°C to 8°C (36°F to 46°F).
• Keep your home safe from the elements and freeze.
• Let the vial be at room temperature before injection.
• Use aseptic technique during administration.

Summary

Conclusion

Lupride Depot 11.25mg is a powerful GnRH agonist that comes in a sustained-release formulation, which allows quarterly doses. It is effective in reducing sex hormone production and is extensively used in the treatment of hormone-dependent disorders such as endometriosis, prostate cancer, as well as uterine fibroids and precocious puberty. A proper administration, surveillance, and education of patients are crucial for maximizing benefits and minimizing negative consequences.